Category Archives: Biotech

Temple Therapeutics BV Announces Publication of Key Mechanism Data for Evitar™

Below, we are re-publishing with permission the press-release issued by Temple Therapeutics BV on the 10th of September 2018 Supports Evitar’s™ Novel Approach for Preventing Acute Tissue Fibrosis (Surgical Adhesions) Geleen, The Netherlands Temple Therapeutics BV (the “Company” or “Temple”)- September … Continue reading

Posted in Biotech, Clinical Accelerator | Leave a comment

Clinical Accelerator announces collaboration with Oncolix for developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Oncolix, for conducting clinical studies for its analogue protein, Prolanta, to treat ovarian cancer. The trials will be conducted in the … Continue reading

Posted in Biotech, Central and Eastern Europe, Clinical Accelerator | Leave a comment